Annual Accounts Payable
$23.69 M
+$18.42 M+349.63%
December 31, 2023
Summary
- As of February 12, 2025, TARS annual accounts payable is $23.69 million, with the most recent change of +$18.42 million (+349.63%) on December 31, 2023.
- During the last 3 years, TARS annual accounts payable has risen by +$21.45 million (+959.05%).
- TARS annual accounts payable is now at all-time high.
Performance
TARS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$26.82 M
+$162.00 K+0.61%
September 30, 2024
Summary
- As of February 12, 2025, TARS quarterly accounts payable is $26.82 million, with the most recent change of +$162.00 thousand (+0.61%) on September 30, 2024.
- Over the past year, TARS quarterly accounts payable has increased by +$8.67 million (+47.75%).
- TARS quarterly accounts payable is now at all-time high.
Performance
TARS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TARS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +349.6% | +47.8% |
| 3 y3 years | +959.0% | +47.8% |
| 5 y5 years | +10000.0% | +47.8% |
TARS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +729.5% | at high | +838.9% |
| 5 y | 5-year | at high | +5095.4% | at high | +5780.5% |
| alltime | all time | at high | >+9999.0% | at high | +5780.5% |
Tarsus Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.82 M(+0.6%) |
| Jun 2024 | - | $26.65 M(+39.2%) |
| Mar 2024 | - | $19.14 M(+5.5%) |
| Dec 2023 | $23.69 M(+349.6%) | $18.15 M(+74.8%) |
| Sep 2023 | - | $10.38 M(+27.0%) |
| Jun 2023 | - | $8.17 M(+8.0%) |
| Mar 2023 | - | $7.57 M(+37.6%) |
| Dec 2022 | $5.27 M | $5.50 M(-1.7%) |
| Sep 2022 | - | $5.59 M(+36.6%) |
| Jun 2022 | - | $4.09 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $4.03 M(+41.0%) |
| Dec 2021 | $2.86 M(+27.7%) | $2.86 M(+42.1%) |
| Sep 2021 | - | $2.01 M(-39.1%) |
| Jun 2021 | - | $3.30 M(-33.9%) |
| Mar 2021 | - | $5.00 M(+123.4%) |
| Dec 2020 | $2.24 M(+390.6%) | $2.24 M(-52.5%) |
| Sep 2020 | - | $4.71 M(+231.4%) |
| Jun 2020 | - | $1.42 M(+211.4%) |
| Dec 2019 | $456.00 K(+160.6%) | $456.00 K |
| Dec 2018 | $175.00 K | - |
FAQ
- What is Tarsus Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual accounts payable year-on-year change?
- What is Tarsus Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly accounts payable year-on-year change?
What is Tarsus Pharmaceuticals annual accounts payable?
The current annual accounts payable of TARS is $23.69 M
What is the all time high annual accounts payable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual accounts payable is $23.69 M
What is Tarsus Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, TARS annual accounts payable has changed by +$18.42 M (+349.63%)
What is Tarsus Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of TARS is $26.82 M
What is the all time high quarterly accounts payable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly accounts payable is $26.82 M
What is Tarsus Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, TARS quarterly accounts payable has changed by +$8.67 M (+47.75%)